The DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.
Ovarian cancer stem-like side-population cells are tumourigenic and chemoresistant
Open accessAbstract
BACKGROUND: Ovarian cancer is the most lethal gynaecological malignancy. Although ovarian cancer patients often respond initially to chemotherapy, they usually develop chemoresistance. We hypothesised that a small portion of ovarian cancer cells have stem-like cell properties that contribute to tumourigenesis and drug resistance. METHODS: Flow cytometry and Hoechst 33342 efflux isolated side-population (SP) cells from ascites derived from ovarian cancer patients and from mice inoculated with human ovarian cancer cell lines. The SP cells were examined for stem cell markers OCT4, NANOG, STELLAR, and ABCG2/BCRP1 by immunocytochemistry and RT-PCR. The SP cells and non-SP cells were studied for tumourigenesis and chemoresistance in vitro and in vivo. RESULTS: The SP cells expressed ABCG2/BCRP1, OCT4, STELLAR, and NANOG, detected by immunocytochemistry and RT-PCR. ABCG2/BCRP1 expression was higher in SP than in non-SP cells. Xenogeneic mice inoculated with SP cells yielded more tumours than did mice inoculated with non-SP cells. In parallel, SP cell culture resulted in extensive cell proliferation, which was markedly more than in non-SP cells. SP cells resisted chemotherapy compared with non-SP cells, both in vivo and in vitro. CONCLUSION: Ovarian cancer SP cells are tumourigenic and chemoresistant. ABCG2/BCRP1 has an important role in chemoresistance, which has implications for new therapeutic approaches.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Stem cells, cancer, and cancer stem cells
Reya, T., Morrison, S. J., Clarke, M. F., & Weissman, I. L. (2001) · Nature · doi:10.1038/35102167 · Cited by 9,738
Tumour stem cells and drug resistance
Dean, M., Fojo, T., & Bates, S. (2005) · Nature reviews. Cancer · doi:10.1038/nrc1590 · Cited by 3,668 · cited 4×
“These cells express drug transporters that make them resistant to many chemotherapeutic agents (Allikmets et al, 1998a; Dean et al, 2005).”
BackgroundInfluentialNichols, J., Zevnik, B., Anastassiadis, K., Niwa, H., Klewe-Nebenius, D., Chambers, I., Schöler, H., & Smith, A. (1998) · Cell · doi:10.1016/s0092-8674(00)81769-9 · Cited by 3,392
Functional Expression Cloning of Nanog, a Pluripotency Sustaining Factor in Embryonic Stem Cells
Chambers, I., Colby, D., Robertson, M., Nichols, J., Lee, S., Tweedie, S., & Smith, A. (2003) · Cell · doi:10.1016/s0092-8674(03)00392-1 · Cited by 3,255
The Homeoprotein Nanog Is Required for Maintenance of Pluripotency in Mouse Epiblast and ES Cells
Mitsui, K., Tokuzawa, Y., Itoh, H., Segawa, K., Murakami, M., Takahashi, K., Maruyama, M., Maeda, M., & Yamanaka, S. (2003) · Cell · doi:10.1016/s0092-8674(03)00393-3 · Cited by 3,191
Ben-Porath, I., Thomson, M. W., Carey, V. J., Ge, R., Bell, G. W., Regev, A., & Weinberg, R. A. (2008) · Nature Genetics · doi:10.1038/ng.127 · Cited by 2,523
A multidrug resistance transporter from human MCF-7 breast cancer cells
Doyle, L. A., Yang, W., Abruzzo, L. V., Krogmann, T., Gao, Y., Rishi, A. K., & Ross, D. D. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.26.15665 · Cited by 2,322
Zhou, S., Schuetz, J. D., Bunting, K. D., Colapietro, A.-M., Sampath, J., Morris, J. J., Lagutina, I., Grosveld, G. C., Osawa, M., Nakauchi, H., et al. (2001) · Nature Medicine · doi:10.1038/nm0901-1028 · Cited by 2,280
Tissue repair and stem cell renewal in carcinogenesis
Beachy, P. A., Karhadkar, S. S., & Berman, D. M. (2004) · Nature · doi:10.1038/nature03100 · Cited by 1,208
Multidrug resistance mediated by the breast cancer resistance protein BCRP (ABCG2)
Austin Doyle, L., & Ross, D. D. (2003) · Oncogene · doi:10.1038/sj.onc.1206938 · Cited by 1,051
Persistence of a small subpopulation of cancer stem-like cells in the C6 glioma cell line
Kondo, T., Setoguchi, T., & Taga, T. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0307618100 · Cited by 985
Side Population in Human Lung Cancer Cell Lines and Tumors Is Enriched with Stem-like Cancer Cells
Ho, M. M., Ng, A. V., Lam, S., & Hung, J. Y. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-3557 · Cited by 947
Miyake, K., Mickley, L. A., Litman, T., Zhan, Z., Robey, R. W., Cristensen, B., Brangi, M., Greenberger, L., Dean, M. C., Fojo, T., et al. (1999) · Research at the University of Copenhagen (University of Copenhagen) · Cited by 929
The Stromal Proteinase MMP3/Stromelysin-1 Promotes Mammary Carcinogenesis
Sternlicht, M. D., Lochter, A., Sympson, C. J., Huey, B., Rougier, J.-P., Gray, J. W., Pinkel, D., Bissell, M. J., & Werb, Z. (1999) · Cell · doi:10.1016/s0092-8674(00)81009-0 · Cited by 924
Allikmets, R., Schriml, L. M., Hutchinson, A. A., Romano-Spica, V., & Dean, M. C. (1998) · PubMed · Cited by 918
Mutations in the SMAD4/DPC4 Gene in Juvenile Polyposis
Howe, J. R., Roth, S., Ringold, J. C., Summers, R. W., Järvinen, H. J., Sistonen, P., Tomlinson, I. P. M., Houlston, R. S., Bevan, S., Mitros, F. A., et al. (1998) · Science · doi:10.1126/science.280.5366.1086 · Cited by 907
Patrawala, L., Calhoun, T., Schneider-Broussard, R., Zhou, J., Claypool, K., & Tang, D. G. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-0592 · Cited by 903
Scharenberg, C. W., Harkey, M. A., & Torok-Storb, B. (2002) · Blood · doi:10.1182/blood.v99.2.507 · Cited by 770
Fuchs, E., & Segre, J. A. (2000) · Cell · doi:10.1016/s0092-8674(00)81691-8 · Cited by 764
Szotek, P. P., Pieretti-Vanmarcke, R., Masiakos, P. T., Dinulescu, D. M., Connolly, D., Foster, R., Dombkowski, D., Preffer, F., MacLaughlin, D. T., & Donahoe, P. K. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0603672103 · Cited by 751
Module Map of Stem Cell Genes Guides Creation of Epithelial Cancer Stem Cells
Wong, D. J., Liu, H., Ridky, T. W., Cassarino, D., Segal, E., & Chang, H. Y. (2008) · Cell Stem Cell · doi:10.1016/j.stem.2008.02.009 · Cited by 720
Characterization of a Side Population of Cancer Cells from Human Gastrointestinal System
Haraguchi, N., Utsunomiya, T., Inoue, H., Tanaka, F., Mimori, K., Barnard, G. F., & Mori, M. (2006) · Stem Cells · doi:10.1634/stemcells.2005-0282 · Cited by 569
Zhou, S., Morris, J. J., Barnes, Y., Lan, L., Schuetz, J. D., & Sorrentino, B. P. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.192276999 · Cited by 502
Kim, M., Turnquist, H. R., Jackson, J. D., Sgagias, M. K., Yan, Y., Gong, M., Dean, M. C., Sharp, J. G., & Cowan, K. H. (2002) · PubMed · Cited by 397
Wang, J., Guo, L.-P., Chen, L.-Z., Zeng, Y.-X., & Lu, S. H. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-4343 · Cited by 363
Malignant transformation in a nontumorigenic human prostatic epithelial cell line.
Hayward, S. W., Wang, Y. Z., Cao, M., Hom, Y. K., Zhang, B., Grossfeld, G. D., Sudilovsky, D., & Cunha, G. R. (2001) · PubMed · Cited by 345
A leukemic stem cell with intrinsic drug efflux capacity in acute myeloid leukemia
Wulf, G. G., Wang, R.-Y., Kuehnle, I., Weidner, D., Marini, F., Brenner, M. K., Andreeff, M., & Goodell, M. A. (2001) · Blood · doi:10.1182/blood.v98.4.1166 · Cited by 326
Functional and molecular characterisation of mammary side population cells
Alvi, A. J., Clayton, H., Joshi, C., Enver, T., Ashworth, A., Vivanco, M. A. M., Dale, T. C., & Smalley, M. J. (2002) · Breast Cancer Research · doi:10.1186/bcr547 · Cited by 289
Diestra, J. E., Scheffer, G. L., Català, I., Maliepaard, M., Schellens, J. H. M., Scheper, R. J., Germà‐Lluch, J. R., & Izquierdo, M. A. (2002) · The Journal of Pathology · doi:10.1002/path.1203 · Cited by 275
Targeted therapy for cancer stem cells: the patched pathway and ABC transporters
Lou, H., & Dean, M. (2007) · Oncogene · doi:10.1038/sj.onc.1210200 · Cited by 239
Side Population Cells Isolated from Mesenchymal Neoplasms Have Tumor Initiating Potential
Wu, C., Wei, Q., Utomo, V., Nadesan, P., Whetstone, H., Kandel, R., Wunder, J. S., & Alman, B. A. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-0999 · Cited by 221
Chiba, T., Miyagi, S., Saraya, A., Aoki, R., Seki, A., Morita, Y., Yonemitsu, Y., Yokosuka, O., Taniguchi, H., Nakauchi, H., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-5882 · Cited by 194
Detection of tumor stem cell markers in pancreatic carcinoma cell lines.
Olempska, M., Eisenach, P. A., Ammerpohl, O., Ungefroren, H., Fändrich, F., & Kalthoff, H. (2007) · PubMed · Cited by 183
Cancer stem cell characteristics in retinoblastoma.
Seigel, G. M., Campbell, L. M., Narayan, M., & Gonzalez-Fernandez, F. (2005) · PubMed · Cited by 171
Cancer Stem Cells Are Enriched in the Side Population Cells in a Mouse Model of Glioma
Harris, M. A., Yang, H., Low, B. E., Mukherje, J., Guha, A., Bronson, R. T., Shultz, L. D., Israel, M. A., & Yun, K. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-0786 · Cited by 170
Hirschmann-Jax, C., Foster, A. E., Wulf, G. G., Goodell, M. A., & Brenner, M. K. (2004) · Cell Cycle · doi:10.4161/cc.4.2.1406 · Cited by 157
Cancer stem cells and their niche
Iwasaki, H., & Suda, T. (2009) · Cancer Science · doi:10.1111/j.1349-7006.2009.01177.x · Cited by 155
Molecular phenotype of airway side population cells
Giangreco, A., Shen, H., Reynolds, S. D., & Stripp, B. R. (2004) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00149.2003 · Cited by 154
Feuring‐Buske, M., & Hogge, D. E. (2001) · Blood · doi:10.1182/blood.v97.12.3882 · Cited by 122
Nishimura, F., Yoshikawa, M., Kanda, S., Nonaka, M., Yokota, H., Shiroi, A., Nakase, H., Hirabayashi, H., Ouji, Y., Birumachi, J., et al. (2003) · Stem Cells · doi:10.1634/stemcells.21-2-171 · Cited by 114
Identification of Novel Resident Pulmonary Stem Cells: Form and Function of the Lung Side Population
Majka, S. M., Beutz, M. A., Hagen, M. E., Izzo, A. A., Voelkel, N. F., & Helm, K. M. (2005) · Stem Cells · doi:10.1634/stemcells.2005-0039 · Cited by 108
Characterization and Localization of Side Population Cells in Mouse Skin
Yano, S., Ito, Y., Fujimoto, M., Hamazaki, T. S., Tamaki, K., & Okochi, H. (2005) · Stem Cells · doi:10.1634/stemcells.2004-0226 · Cited by 91
Ahmed‐Belkacem, A., Pozza, A., Macalou, S., et al. (2006) · Anti-Cancer Drugs · doi:10.1097/00001813-200603000-00001 · Cited by 86
Uchida, N., Leung, F. Y. K., & Eaves, C. J. (2002) · Experimental Hematology · doi:10.1016/s0301-472x(02)00879-2 · Cited by 70
Stem Cells and Cancer: An Overview
Sales, K. M., Winslet, M. C., & Seifalian, A. M. (2007) · Stem Cell Reviews and Reports · doi:10.1007/s12015-007-9002-0 · Cited by 68
Steiniger, S. C. J., Coppinger, J. A., Krüger, J. A., Yates, J. R., & Janda, K. D. (2008) · Stem Cells · doi:10.1634/stemcells.2008-0397 · Cited by 51
ABCG2 (BCRP): a cytoprotectant in normal and malignant stem cells.
Abbott, B. L. (2006) · PubMed · Cited by 42
Cited by
Meeting the challenge of ascites in ovarian cancer: new avenues for therapy and research
Kipps, E., Tan, D. S. P., & Kaye, S. B. (2013) · Nature Reviews Cancer · doi:10.1038/nrc3432 · Cited by 562
Ahmed, N., & Stenvers, K. L. (2013) · Frontiers in Oncology · doi:10.3389/fonc.2013.00256 · Cited by 482
Cancer stem cells and chemoresistance: The smartest survives the raid
Zhao, J. (2016) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2016.02.008 · Cited by 437
Role of breast cancer resistance protein (BCRP/ABCG2) in cancer drug resistance
Natarajan, K., Xie, Y., Baer, M. R., & Ross, D. D. (2012) · Biochemical Pharmacology · doi:10.1016/j.bcp.2012.01.002 · Cited by 405
ABC Transporters in Cancer Stem Cells: Beyond Chemoresistance
Begicevic, R.-R., & Falasca, M. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18112362 · Cited by 395
Metadata
- Authors
- Hu, L., McArthur, C., & Jaffe, R. B.
- Venue
- British Journal of Cancer
- Published
- 2010-03-30
- Volume
- 102
- Issue
- 8
- Pages
- 1276-1283
- ISSN
- 0007-0920 (ISSN-L)
- 1532-1827
- OpenAlex
- W2077223423
- Cited by
- 296
- References
- 47
- FWCI
- 13.39
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.